Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease, affecting 0.7% of the elderly population (defined as over 65 years of age). PD is clinically characterized by resting tremor, muscular rigidity, hypokinesia and postural instability. These motor symptoms result largely from the deficiency or dysfunction of dopaminergic neurons in the substantia nigra. Histopathological analysis reveals depletion of dopaminergic neurons as well as eosinophilic intracytoplasmic inclusions (Lewy bodies) in surviving neurons of the substantia nigra and other brain regions. The molecular pathogenesis is linked to protein misfolding by compromised alpha-synuclein and/or related proteins (synucleinopathy). Therefore, successful therapy of motor symptoms aims for the restoration of dopaminergic neurotransmission. Pharmacological drug treatment is usually effective only at an early stage of the disease but cannot halt progressive neuronal degeneration. With recent developments in stem cell technology, cell repair or replacement approaches came into focus. Here, we review new therapeutic strategies resulting from the innate propensity of the adult brain to generate new neurons, either by pharmacological stimulation of endogenous adult stem cell population or exogenous cell transplantation modalities.
Ahlskog, J.E. (2007) Beating a dead horse: dopamine and Parkinson disease , Neurology69: 1701-1711.
2.
Baker, S.A., Baker, K.A. and Hagg, T. (2004) Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone, Eur J Neurosci20: 575-579.
3.
Belin, A.C. and Westerlund, M. (2008) Parkinson's disease: a genetic perspective, FEBS J275: 1377-1383.
4.
Bjorklund, A., Dunnett, S.B., Brundin, P., Stoessl, A.J., Freed, C.R., Breeze, R.E. et al. (2003) Neural transplantation for the treatment of Parkinson's disease, Lancet Neurol2: 437-445.
5.
Borta, A. and Hoglinger, G.U. (2007) Dopamine and adult neurogenesis, J Neurochem100: 587-595.
6.
Braak, H. and Del Tredici, K. (2008) Assessing fetal nerve cell grafts in Parkinson's disease, Nat Med14: 483-485.
7.
Castelo-Branco, G. and Arenas, E. (2006) Function of Wnts in dopaminergic neuron development , Neurodegener Dis3: 5-11.
8.
Chen, Y., Ai, Y., Slevin, J.R., Maley, B.E. and Gash, D.M. (2005) Progenitor proliferation in the adult hippocampus and substantia nigra induced by glial cell line-derived neurotrophic factor , Exp Neurol196: 87-95.
9.
Doetsch, F. (2003) A niche for adult neural stem cells, Curr Opin Genet Dev13: 543-550.
10.
Freed, C.R., Greene, P.E., Breeze, R.E., Tsai, W.Y., Dumouchel, W., Kao, R. et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease, N Engl J Med344: 710-719.
Gasser, T. (2007) Update on the genetics of Parkinson's disease, Mov Disord22: S343-S350.
13.
Hagell, P. and Brundin, P. (2001) Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease, J Neuropathol Exp Neurol60: 741-752.
14.
Harding, A.J. and Halliday, G.M. (2001) Cortical Lewy body pathology in the diagnosis of dementia, Acta Neuropathol (Berl)102: 355-363.
15.
Hauser, R.A., Freeman, T.B., Snow, B.J., Nauert, M., Gauger, L., Kordower, J.H. et al. (1999) Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease, Arch Neurol56: 179-187.
16.
Hoglinger, G.U., Rizk, P., Muriel, M.P., Duyckaerts, C., Oertel, W.H., Caille, I. et al. (2004) Dopamine depletion impairs precursor cell proliferation in Parkinson disease, Nat Neurosci7: 726-735.
17.
Huisman, E., Uylings, H.B. and Hoogland, P.V. (2004) A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease, Mov Disord19: 687-692.
18.
Kawasaki, H., Mizuseki, K., Nishikawa, S., Kaneko, S., Kuwana, Y., Nakanishi, S. et al. (2000) Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity, Neuron28: 31-40.
19.
Kordower, J.H., Chu, Y., Hauser, R.A., Freeman, T.B. and Olanow, C.W. (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease, Nat Med14: 504-506.
20.
Kordower, J.H., Freeman, T.B., Snow, B.J., Vingerhoets, F.J., Mufson, E.J., Sanberg, P.R. et al. (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease, N Engl J Med332: 1118-1124.
21.
Lee, S.H., Lumelsky, N., Studer, L., Auerbach, J.M. and McKay, R.D. (2000) Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cell, Nat Biotechnol18: 675-679.
22.
Li, J.Y., Englund, E., Holton, J.L., Soulet, D., Hagell, P., Lees, A.J. et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation, Nat Med14: 501-503.
23.
Lie, D.C., Dziewczapolski, G., Willhoite, A.R., Kaspar, B.K., Shults, C.W. and Gage, F.H. (2002) The adult substantia nigra contains progenitor cells with neurogenic potential, J Neurosci22: 6639-6649.
24.
Lindvall, O., Sawle, G., Widner, H., Rothwell, J.C., Bjorklund, A., Brooks, D. et al. (1994) Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease, Ann Neurol35: 172-180.
25.
Maciaczyk, J., Singec, I., Maciaczyk, D. and Nikkhah, G. (2008) Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells, Exp Neurol213: 354-362.
26.
Mao, L., Lau, Y.S., Petroske, E. and Wang, J.Q. (2001) Profound astrogenesis in the striatum of adult mice following nigrostriatal dopaminergic lesion by repeated MPTP administration , Brain Res Dev Brain Res131: 57-65.
27.
Mendez, I., Sanchez-Pernaute, R., Cooper, O., Vinuela, A., Ferrari, D., Bjorklund, L. et al. (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with parkinson's disease, Brain128: 1498-1510.
28.
Mendez, I., Vinuela, A., Astradsson, A., Mukhida, K., Hallett, P., Robertson, H. et al. (2008) Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years, Nat Med14: 507-509.
29.
Meredith, G.E., Sonsalla, P.K. and Chesselet, M.F. (2008) Animal models of Parkinson's disease progression , Acta Neuropathol115: 385-398.
30.
Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E. et al. (2006) Exogenous induction of cerebral betaamyloidogenesis is governed by agent and host, Science313: 1781-1784.
31.
Meyer-Luehmann, M., Spires-Jones, T.L., Prada, C., Garcia-Alloza, M., De Calignon, A., Rozkalne, A. et al. (2008) Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease, Nature451: 720-724.
32.
Ming, G.L. and Song, H. (2005) Adult neurogenesis in the mammalian central nervous system, Annu Rev Neurosci28: 223-250.
33.
Mohapel, P., Frielingsdorf, H., Haggblad, J., Zachrisson, O. and Brundin, P. (2005) Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions, Neuroscience132: 767-776.
34.
Olanow, C.W., Goetz, C.G., Kordower, J.H., Stoessl, A.J., Sossi, V., Brin, M.F. et al. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease, Ann Neurol54: 403-414.
35.
Olanow, C.W., Kordower, J.H. and Freeman, T.B. (1996) Fetal nigral transplantation as a therapy for Parkinson's disease, Trends Neurosci19: 102-109.
36.
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G. et al. (2003) Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis, Nature422: 688-694.
37.
Prakash, N. and Wurst, W. (2006) Genetic networks controlling the development of midbrain dopaminergic neurons, J Physiol575: 403-410.
38.
Prakash, N. and Wurst, W. (2007) A Wnt signal regulates stem cell fate and differentiation in vivo, Neurodegener Dis4: 333-338.
39.
Reimers, D., Herranz, A.S., Diaz-Gil, J.J., Lobo, M.V., Paino, C.L., Alonso, R. et al. (2006) Intrastriatal infusion of liver growth factor stimulates
40.
dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats, J Histochem Cytochem 54: 457-465.
41.
Shan, X., Chi, L., Bishop, M., Luo, C., Lien, L., Zhang, Z. et al. (2006) Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of MPTP-induced Parkinson's disease-like mice, Stem Cells24: 1280-1287.
42.
Shults, C.W. (2006) Lewy bodies, Proc Natl Acad Sci U S A103: 1661-1668.
43.
Siebzehnrubl, F. and Blumcke, I. (2008) Neurogenesis in the human hippocampus and its relevance to temporal lobe epilepsies, Epilepsia49: 55-65.
44.
Siebzehnrubl, F.A., Jeske, I., Muller, D., Buslei, R., Coras, R., Hahnen, E. et al. (2008) Spontaneous in vitro transformation of adult neural precursors into stem-like cancer cells, Brain Pathol2008 Jul 10 [Epub ahead of print].
45.
Smidt, M.P. and Burbach, J.P. (2007) How to make a mesodiencephalic dopaminergic neuron , Nat Rev Neurosci8: 21-32.
46.
Spillantini, M., Schmidt, M., Lee, V.-Y., Trojanowski, J., Jakes, R. and Goedert, M. (1997) A-synuclein in Lewy bodies, Nature388: 839-840.
47.
Steiner, B., Winter, C., Hosman, K., Siebert, E., Kempermann, G., Petrus, D.S. et al. (2006) Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease, Exp Neurol199: 291-300.
48.
Sulzer, D. (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease, Trends in Neurosciences30: 244-250.
49.
Takagi, Y., Takahashi, J., Saiki, H., Morizane, A., Hayashi, T., Kishi, Y. et al. (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model, J Clin Invest115: 102-109.
50.
Takahashi, J. (2007) Stem cell therapy for Parkinson's disease, Expert Rev Neurother7: 667-675.
51.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell131: 861-872.
52.
Takeda, A., Mallory, M., Sundsmo, M., Honer, W., Hansen, L. and Masliah, E. (1998) Abnormal accumulation of Nacp/α-Synuclein in neurodegenerative disorders, Am J Pathol152: 367-372.
53.
Terzioglu, M. and Galter, D. (2008) Parkinson's disease: genetic versus toxin-induced rodent models, FEBS J275: 1384-1391.
54.
Thomas, B. and Beal, M.F. (2007) Parkinson's disease, Hum Mol Genet16 Spec No. 2: R183-194.
55.
Trenkwalder, C., Schwarz, J., Gebhard, J., Ruland, D., Trenkwalder, P., Hense, H.W. et al. (1995) Starnberg trial on epidemiology of parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years , Arch Neurol52: 1017-1022.
56.
Trojanowski, J.Q. and Lee, V.M. (1998) Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia, Arch Neurol55: 151-152.
57.
Van Kampen, J.M. and Eckman, C.B. (2006) Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior, J Neurosci26: 7272-7280.
58.
Van Kampen, J.M. and Robertson, H.A. (2005) A possible role for dopamine D3 receptor stimulation in the induction of neurogenesis in the adult rat substantia nigra, Neuroscience136: 381-386.
59.
Wakabayashi, K., Matsumoto, K., Takayama, K., Yoshimoto, M. and Takahashi, H. (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease, Neurosci Lett239: 45-48.
60.
Walton, N.M., Sutter, B.M., Chen, H.X., Chang, L.J., Roper, S.N., Scheffler, B. et al. (2006) Derivation and large-scale expansion of multipotent astroglial neural progenitors from adult human brain, Development133: 3671-3681.
61.
Wenning, G.K., Odin, P., Morrish, P., Rehncrona, S., Widner, H., Brundin, P. et al. (1997) Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease, Ann Neurol42: 95-107.
62.
Wernig, M., Zhao, J.P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F. et al. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease, Proc Natl Acad Sci USA105: 5856-5861.
63.
Winner, B., Couillard-Despres, S., Geyer, M., Aigner, R., Bogdahn, U., Aigner, L. et al. (2008) Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration, J Neuropathol Exp Neurol67: 105-116.
64.
Winner, B., Geyer, M., Couillard-Despres, S., Aigner, R., Bogdahn, U., Aigner, L. et al. (2006) Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb, Exp Neurol197: 113-121.
65.
Yamada, M., Onodera, M., Mizuno, Y. and Mochizuki, H. (2004) Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice, Neuroscience124: 173-181.
66.
Yoshimi, K., Ren, Y.R., Seki, T., Yamada, M., Ooizumi, H., Onodera, M. et al. (2005) Possibility for neurogenesis in substantia nigra of Parkinsonian brain, Ann Neurol58: 31-40.
67.
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S. et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells, Science318: 1917-1920.
68.
Zhao, C., Teng, E.M., Summers, R.G., Jr., Ming, G.L. and Gage, F.H. (2006) Distinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus, J Neurosci26: 3-11.
